As of April 2024 OPKO Health has a market cap of $0.85 Billion. This makes OPKO Health the world's 5296th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.85 B | -26.56% |
2023 | $1.16 B | 20.86% |
2022 | $0.96 B | -70.53% |
2021 | $3.27 B | 23.83% |
2020 | $2.64 B | 168.78% |
2019 | $0.98 B | -44.21% |
2018 | $1.76 B | -35.61% |
2017 | $2.74 B | -47.14% |
2016 | $5.18 B | -5.35% |
2015 | $5.47 B | 26.88% |
2014 | $4.31 B | 23.99% |
2013 | $3.48 B | 136.91% |
2012 | $1.46 B | 3.33% |
2011 | $1.42 B | 51.74% |
2010 | $0.93 B | 101.85% |
2009 | $0.46 B | 44.24% |
2008 | $0.32 B | -36.66% |
2007 | $0.50 B | 3419.37% |
2006 | $14.44 M | 108.71% |
2005 | $6.91 M | 25.42% |
2004 | $5.51 M | -60.92% |
2003 | $14.11 M | 149.22% |
2002 | $5.66 M | -89.49% |
2001 | $53.88 M |
On Apr 24th, 2024 the market cap of OPKO Health was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $357.92 B | 41,650.21% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $185.47 B | 21,534.59% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $99.50 B | 11,506.63% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.02 B | 11,451.09% | ๐บ๐ธ USA |
LabCorp LH | $17.49 B | 1,940.49% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $18.18 B | 2,021.05% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $14.73 B | 1,618.84% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $1.49 B | 74.52% | ๐บ๐ธ USA |